(Q48255525)

English

Efficacy and safety of risperidone in the treatment of elderly patients suffering from organic brain disease (organic brain syndrome): results from a double-blind, randomized, placebo-controlled clinical trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17333131

Efficacy and safety of risperidone in the treatment of elderly patients suffering from organic brain disease (organic brain syndrome): results from a double-blind, randomized, placebo-controlled clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17333131

organic brain syndrome

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Dieter Naber

1

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17333131

Andrew Greenspan

2

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17333131

Andreas Schreiner

3

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17333131

publication date

27 February 2007

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17333131

Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17333131

191

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17333131

4

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17333131

1027-1029

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17333131

https://scigraph.springernature.com/pub.10.1007/s00213-007-0747-6

0 references

Risperidone treatment in elderly patients with dementia: relative risk of cerebrovascular events versus other antipsychotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/17333131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17333131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Managing the behavioral and psychological signs and symptoms of dementia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17333131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cerebrovascular events among elderly nursing home patients treated with conventional or atypical antipsychotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/17333131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials

1 reference

https://pubmed.ncbi.nlm.nih.gov/17333131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17333131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function

1 reference

https://pubmed.ncbi.nlm.nih.gov/17333131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atypical antipsychotic drugs and risk of ischaemic stroke: population based retrospective cohort study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17333131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality in elderly dementia patients treated with risperidone.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17333131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International Multisite Double-Blind Trial of the Atypical Antipsychotics Risperidone and Olanzapine in 175 Elderly Patients With Chronic Schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/17333131

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00213-007-0747-6

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17333131

release_ypmjzsdsgvcvxccnkup2ggpwle

1 reference

https://api.fatcat.wiki/v0/release/ypmjzsdsgvcvxccnkup2ggpwle

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 February 2018

http://europepmc.org/abstract/MED/17333131

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48255525&oldid=2193104351"